Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot
Code deleted, see 80358

Official Description

Methadone

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 83840 refers to a laboratory test specifically designed to measure the levels of methadone in various biological samples, including blood, urine, or meconium stool. Methadone is classified as a synthetic opioid, which means it is a man-made substance that mimics the effects of natural opiates. It is primarily utilized in the management of moderate to severe chronic pain and plays a crucial role in treating individuals undergoing withdrawal from other opiate drugs. The testing process involves obtaining a sample, which can be collected through venipuncture for blood, or through a random voided urine sample, or from meconium stool collected from a newborn's diaper. The analysis of these samples is conducted using a sophisticated technique known as quantitative liquid chromatography-tandem mass spectrometry, which allows for precise measurement of methadone levels in the tested specimens. This test is essential for monitoring therapeutic levels of methadone in patients, ensuring effective pain management, and preventing potential overdose or withdrawal symptoms.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The methadone test (CPT® Code 83840) is indicated for several specific clinical scenarios, particularly in the context of pain management and substance use treatment. The following conditions warrant the performance of this test:

  • Monitoring Methadone Therapy This test is performed to monitor patients who are receiving methadone as part of their treatment regimen for chronic pain or opioid dependence, ensuring that the drug levels remain within a therapeutic range.
  • Assessment of Opiate Withdrawal The test may be indicated for patients experiencing withdrawal symptoms from other opiate drugs, allowing healthcare providers to evaluate the effectiveness of methadone in alleviating these symptoms.
  • Verification of Compliance The test can be used to confirm adherence to prescribed methadone therapy, helping to identify any potential misuse or diversion of the medication.

2. Procedure

The procedure for testing methadone levels involves several key steps, each critical to ensuring accurate results. The following outlines the procedural steps involved:

  • Step 1: Sample Collection The first step in the procedure is the collection of the appropriate biological sample. For blood testing, a venipuncture is performed to obtain a blood sample, which is necessary for serum or plasma analysis. In cases where urine testing is required, a random voided urine sample is collected from the patient. Additionally, for newborns, meconium stool is collected from the infant's diaper, which serves as a valuable specimen for testing methadone exposure.
  • Step 2: Sample Preparation Once the samples are collected, they must be prepared for analysis. This involves processing the blood sample to separate the serum or plasma, as well as ensuring that urine and meconium samples are appropriately handled to maintain their integrity for testing.
  • Step 3: Testing Methodology The prepared samples are then subjected to quantitative liquid chromatography-tandem mass spectrometry (LC-MS/MS). This advanced analytical technique allows for the precise quantification of methadone levels in the samples, providing reliable data for clinical interpretation.

3. Post-Procedure

After the methadone testing procedure is completed, the samples are analyzed, and results are typically available within a specified timeframe, depending on the laboratory's processing capabilities. Healthcare providers will review the results to assess the methadone levels in the patient's system. Based on these results, further clinical decisions may be made regarding the patient's treatment plan, including adjustments to methadone dosage or additional interventions if necessary. It is important for healthcare professionals to communicate the results to the patient and discuss any implications for their ongoing treatment and care.

Short Descr ASSAY OF METHADONE
Medium Descr METHADONE
Long Descr Methadone
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 9 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Items and Services Packaged into APC Rates
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE Not applicable/unspecified.
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
Date
Action
Notes
2015-01-01 Deleted Code deleted, see 80358
Pre-1990 Added Code added.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"